Reprogramming metabolism by histone methyltransferase NSD2 drives endocrine resistance via coordinated activation of

Junjian Wang1, Zhijian Duan1, Zoann Nugent2

  • 1Department of Biochemistry and Molecular Medicine, School of Medicine, University of California, Davis, Sacramento, CA 95817, United States.

Cancer Letters
|May 11, 2016
PubMed

Insights

The histone methyltransferase NSD2 drives tamoxifen resistance in breast cancer by epigenetically upregulating glucose metabolism enzymes. This suggests NSD2 as a therapeutic target for endocrine-resistant breast cancer.

Area of Science:

  • Oncology
  • Epigenetics
  • Cancer Metabolism

Background:

  • Metabolic reprogramming, including the Warburg effect, is a hallmark of cancer.
  • Molecular mechanisms of metabolic alterations contributing to therapeutic resistance remain unclear.
  • Endocrine resistance is a significant challenge in breast cancer treatment.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying metabolic alterations in tamoxifen-resistant breast cancer.
  • To identify potential therapeutic targets for endocrine-resistant breast cancer.

Main Methods:

  • Gene expression profiling of tamoxifen-resistant breast cancer cell lines and tumors.
  • Immunohistochemistry (IHC) to assess NSD2 protein levels.
  • Functional studies involving ectopic expression of NSD2 and its mutants in cell models and xenografts.
  • Analysis of glucose metabolic enzyme gene expression and pathway activity (glycolysis, pentose phosphate pathway).

Main Results:

  • NSD2 (histone H3K36 methyltransferase) expression is elevated in tamoxifen-resistant breast cancer.
  • NSD2 overexpression correlates with disease recurrence and poor survival.
  • NSD2 drives endocrine resistance by methylating H3K36me2 at promoters of key metabolic enzymes, including HK2 and G6PD.
  • NSD2 upregulates the pentose phosphate pathway (PPP), increasing NADPH and reducing reactive oxygen species (ROS) in resistant cells.

Conclusions:

  • NSD2 epigenetically activates key glucose metabolic enzymes, contributing to tamoxifen resistance in breast cancer.
  • NSD2 plays a crucial role in metabolic reprogramming associated with therapeutic resistance.
  • NSD2 is a potential therapeutic target for overcoming endocrine resistance in breast cancer.

Related Concept Videos

Regulation of Metabolism01:19

Regulation of Metabolism

Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
12.1K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
4.1K
Epigenetic Regulation01:46

Epigenetic Regulation

26.2K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
34.2K
Chromatin Modification in iPS Cells01:32

Chromatin Modification in iPS Cells

Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
2.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K